Citations 1
A phase II prospective trial correlating progression-free survival (PFS) with CYP2D6 activity in patients with metastatic breast cancer treated with tamoxifen: ECOG-ACRIN E3108.
O’Neill, Anne, Schneider, Bryan P. , Flockhart, David A., Skaar, Todd C. , Liu, Minetta C. , Lohrisch, Caroline , Sologuren, Carlos Vallejos, Villa, Diego , Silverman, Paula , Cheema, P. , Moore, Dennis F., Stearns, Vered , Goetz, Matthew P. , Sparano, Joseph A. , Sledge, George W.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 546-546
